XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 Latest Research
  Personality Disorders
  Substance Abuse
   Bipolar Disorder
  Child Psychiatry
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Anorexia Nervosa
 Infectious Diseases
 Respiratory Medicine
 Public Health
 Clinical Trials
 Medical News
 Awards & Prizes
 Special Topics
 Odd Medical News
 World News

Last Updated: Aug 19th, 2006 - 22:18:38

Psychoses Channel
subscribe to Psychoses newsletter

Latest Research : Psychiatry : Psychoses

   DISCUSS   |   EMAIL   |   PRINT
Early Intervention Services in Psychosis Can Achieve Better Outcomes - Study
Jan 23, 2006, 17:14, Reviewed by: Dr. Ankush Vidyarthi

Despite these benefits, it appears that the specialist early onset service does not specifically improve persisting symptoms, such as positive psychotic symptoms or depression.

A new study has found that specialised care for early psychosis can achieve better outcomes than standard care.

Patients treated by an 'early onset' team were significantly better after 18 months in terms of social and vocational functioning, quality of life, satisfaction and adherence to medication.

The provision of early intervention services for people with psychosis is UK government policy, although until now evidence for its effectiveness has been sparse.

This study was one of the first UK randomised controlled trials to report the effects of an early intervention service. Published in the January 2006 issue of the British Journal of Psychiatry, it compared the outcomes of the work of the Lambeth Early Onset team, which provides specialised care for early psychosis, with existing services.

The Lambeth team was established in January 2000 on principles of assertive outreach, providing a single point of access for all the mental health and social welfare needs of its patients.

This multidisciplinary team included one team leader, one part-time consultant psychiatrist, one trainee psychiatrist, a half-time clinical psychologist, one occupational therapist, four community psychiatric nurses and two healthcare assistants.

It operated an extended hours service between 8am and 8pm five days a week, and between 9am and 5pm at weekends and on public holidays. The interventions provided were specially adapted for a group with early psychosis - a mix of medication management, cognitive behavioural therapy, vocational input and family interventions, according to individual need.

144 people with psychosis attending mental health services for the first or second time (if they previously failed to engage in treatment) were randomly allocated to care from the early onset team, or to standard care from a community mental health sector team.

Information was obtained on symptoms, treatment adherence, social and vocational functioning, satisfaction and quality of life. Participants were studied at baseline and again 18 months later.

The results of the study indicated that the provision of a specialist service for people early in the course of psychosis has a range of benefits. At 18 months it had superior outcomes to standard care in:

* regaining or establishing social relationships
* time spent in vocational activity
* better overall ability to manage the tasks of everyday life
* levels of satisfaction with services
* a higher reported quality of life
* adherence to medication.

These are in addition to the previously reported benefits of increased contact with services, and reduction in hospitalisation.

Despite these benefits, it appears that the specialist early onset service does not specifically improve persisting symptoms, such as positive psychotic symptoms or depression.

The authors of the study conclude that a systematic approach to monitoring and preventing the early development of persisting psychotic symptoms should be taken.

- Garety PA, Craig TKJ, Dunn G, Fornells-Ambrojo M, Colbert S, Rahaman N, Reed J and Power P (2006) Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. British Journal of Psychiatry, 188, 37-45.


Subscribe to Psychoses Newsletter
E-mail Address:


Related Psychoses News

Second-generation antipsychotic medications appear to offer little advantage
Study aims to identify schizophrenics at risk for type 2 diabetes
New Treatment Model for Bipolar Disorder Shows Promise
Effects of ketamine mimic only some of the symptoms of schizophrenia
Association between famine and schizophrenia may yield clues about genetic basis
Neuropeptide S (NPS) may help in treating schizophrenia
Clozapine causes significantly higher rates of metabolic syndrome
Neuropeptide S (NPS) may help in treating schizophrenia
NMDA receptor hypofunction demonstrated in schizophrenia
Altered NRG1-erbB4 signaling may contribute to NMDA receptor hypofunction in schizophrenia

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page


© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us